👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

London stocks gain on quicker recovery hopes; Vodafone jumps

Published 03/02/2021, 09:18
Updated 03/02/2021, 09:24
© Reuters.
UK100
-
VOD
-
GSK
-
FTMC
-
FTNMX405010
-
FTNMX303010
-
GLEN
-
5CV
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* FTSE 100 up 0.8%, FTSE 250 adds 0.7%

Feb 3 (Reuters) - British shares rose for a third straight
session on Wednesday, as investors hoped for a faster economic
revival due to a slew of favourable earnings updates and quicker
vaccine rollouts, while Vodafone jumped after its earnings beat
estimates.
The blue-chip FTSE 100 index .FTSE climbed 0.8%, with
insurance .FTNMX8570 and travel .FTNMX5750 stocks leading
the gains, while the mid-cap index .FTMC added 0.7%.
Markets in Asia and the United States rose on renewed hopes
for U.S. President Joe Biden's proposed $1.9 trillion COVID-19
aid bill and an acceleration in vaccine roll-out programmes.
MKTS/GLOB
Vodafone VOD.L , the world's second-largest mobile
operator, rose 4.4% and was the top boost to the FTSE 100 after
saying its organic service revenue returned to growth in its
third quarter, beating analysts' expectations. nL8N2K91JJ]
Drugmaker GlaxoSmithKline GSK.L gained 0.3% as it struck a
150 million euros ($180 million) deal to develop next-generation
vaccines against COVID-19 with German biotech firm CureVac
5CV.DE . Glencore GLEN.L which mines coal, nickel, silver, zinc and
copper, climbed 0.6% after it stuck to all of its production
targets for 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.